Discovery of a murine model of clinical PAH: Mission impossible?
- 15 December 2016
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 27 (4) , 229-236
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- HIF2α–arginase axis is essential for the development of pulmonary hypertensionProceedings of the National Academy of Sciences, 2016
- Pulmonary arterial hypertension: basis of sex differences in incidence and treatment responseBritish Journal of Pharmacology, 2014
- Selective Inactivation of PTEN in Smooth Muscle Cells Synergizes With Hypoxia to Induce Severe Pulmonary HypertensionJournal of the American Heart Association, 2013
- Allosteric inhibition of hypoxia inducible factor-2 with small moleculesNature Chemical Biology, 2013
- A brief overview of mouse models of pulmonary arterial hypertension: problems and prospectsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 ( ALK1 ) MutationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Oxidative Stress in Severe Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout miceProceedings of the National Academy of Sciences, 2002
- Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse lineGenesis, 2001
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl HydroxylationScience, 2001